Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

9-11 Week Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Study to Determine Effects of Adjunctive Levetiracetam on Sleep Architecture of Adults With Partial Onset Epilepsy Receiving a First Generation Anti-epileptic Drug.

NCT00245713 is registered in ClinicalTrials.gov with UCB Pharma as lead sponsor.

NCT NCT00245713
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00245713 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
9-11 Week Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Study to Determine Effects of Adjunctive Levetiracetam on Sleep Architecture of Adults With Partial Onset Epilepsy Receiving a First Generation Anti-epileptic Drug.
Lead sponsor
UCB Pharma
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2003
Completion date
November 30, 2004
Enrollment
40
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

epilepsy, partial